Atlas Trials

Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors

Clinical trial NCT03257670 · UNKNOWN

Trial details

NCT number
NCT03257670
Sponsor
University of Cincinnati
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Dyspareunia
Start date
2018-03-20
Primary completion
2022-01-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.